Información
This podcast will feature host Dr. Stephen Gately, PhD, President & CEO of TD2, as he discusses the complex challenges of drug development and innovative technologies in a new podcast...
mostra más
This podcast will feature host Dr. Stephen Gately, PhD, President & CEO of TD2, as he discusses the complex challenges of drug development and innovative technologies in a new podcast series dedicated to the evolution of oncology therapeutics
mostra menos
Evolution and Innovation in Oncology Therapeutics Development
Evolution and Innovation in Oncology Therapeutics Development
The importance of metabolic and proteomic analyses in identifying treatment pathways for cancer patients
11 SEP. 2023 · Listen in as the CEO of TD2, Dr. Stephen Gately, sits down with Dr. Ed Weinstein, co-founder and CEO of Panome Bio, to discuss their important research on metabolomics and proteomics. Gain insights into new screening technology for important metabolic and proteomic changes that occur in response to new drugs in development for cancer patients.
Biomarkers and the Utility of Proteomics for Dose Optimization and Confirmation of Target Engagement
30 SEP. 2022 · In this inaugural episode, Dr. Gately sits down with Dr. Emanuel “Chip” Petricoin, professor at George Mason University in the School of Systems Biology, Co-Director of the Center for Applied Proteomics and Molecular Medicine and founder and chairman of the scientific advisory board at Theralink Technologies. The two delve into a deep discussion on the development of Reverse Phase Protein Array technology, the importance of next-generation sequencing in partnership with proteomic analyses, and much more.
This podcast will feature host Dr. Stephen Gately, PhD, President & CEO of TD2, as he discusses the complex challenges of drug development and innovative technologies in a new podcast...
mostra más
This podcast will feature host Dr. Stephen Gately, PhD, President & CEO of TD2, as he discusses the complex challenges of drug development and innovative technologies in a new podcast series dedicated to the evolution of oncology therapeutics
mostra menos
Información
| Autor | Industry Dive's studioID |
| Organización | Industry Dive's studioID |
| Categorías | Medicina |
| Página web | - |
| - |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
